Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diagnostic value of α-synuclein seeding amplification assays in α-synucleinopathies: A systematic review and meta-analysis
Dallah Yoo, Ji-In Bang, Choonghyun Ahn, et al.
Parkinsonism & Related Disorders (2022) Vol. 104, pp. 99-109
Closed Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria
Günter U. Höglinger, Charles H. Adler, Daniela Berg, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 191-204
Closed Access | Times Cited: 203
Clinical Diagnostic Accuracy of Parkinson's Disease: Where Do We Stand?
Sasivimol Virameteekul, Tamás Révész, Zane Jaunmuktane, et al.
Movement Disorders (2023) Vol. 38, Iss. 4, pp. 558-566
Closed Access | Times Cited: 51
Dermal Real‐Time Quaking‐Induced Conversion Is a Sensitive Marker to Confirm Isolated Rapid Eye Movement Sleep Behavior Disorder as an Early α‐Synucleinopathy
Anastasia Kuzkina, Celine Panzer, Aline Seger, et al.
Movement Disorders (2023) Vol. 38, Iss. 6, pp. 1077-1082
Open Access | Times Cited: 23
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers
Lucy L. Gibson, Carla Abdelnour, Joyce R. Chong, et al.
Current Opinion in Neurology (2023)
Open Access | Times Cited: 23
Defining Parkinson’s Disease: Past and Future
Kristína Kulcsarová, Matěj Škorvánek, Ronald B. Postuma, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. s2, pp. S257-S271
Open Access | Times Cited: 9
Research Priorities on the Role of α‐Synuclein in Parkinson's Disease Pathogenesis
Jacqueline Burré, Robert H. Edwards, Glenda M. Halliday, et al.
Movement Disorders (2024) Vol. 39, Iss. 10, pp. 1663-1678
Open Access | Times Cited: 8
Toward alpha‐synuclein seed amplification assay in clinical practice
Mathieu Verdurand, Flora Kaczorowski, Sophie Dautricourt, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
PIDGN: An explainable multimodal deep learning framework for early prediction of Parkinson's disease
Wenjia Li, Qiu Rao, Shuying Dong, et al.
Journal of Neuroscience Methods (2025), pp. 110363-110363
Closed Access | Times Cited: 1
How should we be using biomarkers in trials of disease modification in Parkinson’s disease?
Nirosen Vijiaratnam, Thomas Foltynie
Brain (2023) Vol. 146, Iss. 12, pp. 4845-4869
Open Access | Times Cited: 17
Comparison of biospecimens for α‐synuclein seed amplification assays in Parkinson's disease: A systematic review and network meta‐analysis
Yuanchu Zheng, Siming Li, Yang Chen, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 12, pp. 3949-3967
Closed Access | Times Cited: 16
Detection of α‐Synuclein in Oral Mucosa by Seed Amplification Assay in Synucleinopathies and Isolated REM Sleep Behavior Disorder
Yuanchu Zheng, Zhenwei Yu, Huihui Cai, et al.
Movement Disorders (2024) Vol. 39, Iss. 8, pp. 1300-1309
Open Access | Times Cited: 5
How to advance the pharmacological management of cognitive impairment in Parkinson's disease
Carla Abdelnour, Lucy L. Gibson, Lucia Batzu, et al.
Journal of Parkinson s Disease (2025)
Open Access
A quantitative Lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson’s disease
Alexander Bernhardt, Sebastian Longen, Svenja V. Trossbach, et al.
Acta Neuropathologica (2025) Vol. 149, Iss. 1
Open Access
Biomarker‐Based Approach to α‐Synucleinopathies: Lessons from Neuropathology
Gábor G. Kovács, Lea T. Grinberg, Glenda M. Halliday, et al.
Movement Disorders (2024)
Open Access | Times Cited: 4
Prodromal Parkinson’s Disease
Iro Boura, Karolina Popławska-Domaszewicz, Naomi Limbachiya, et al.
Neurologic Clinics (2025)
Closed Access
Overlapping presence of β-amyloid, tau, p-tau, and α-synuclein in skin nerve fibers in Alzheimer's disease
Emilie Buchholz, Marie-Luise Machule, Maria Buthut, et al.
Journal of Neurology (2025) Vol. 272, Iss. 3
Open Access
Alzheimer’s disease and related dementias diagnosis: a biomarkers meta-analysis of general and CNS extracellular vesicles
Hash Brown Taha
(2025) Vol. 1, Iss. 1
Open Access
The unique neuropathological vulnerability of the human brain to aging
Isidró Ferrer
Ageing Research Reviews (2023) Vol. 87, pp. 101916-101916
Open Access | Times Cited: 11
Challenges and Future of the International Parkinson and Movement Disorder Society Prodromal Parkinson's Disease Criteria: Are We On the Right Track?
Kristína Kulcsarová, Matěj Škorvánek
Movement Disorders (2024) Vol. 39, Iss. 4, pp. 637-643
Closed Access | Times Cited: 3
Extracellular Vesicles for Alzheimer’s Disease and Dementia Diagnosis
Hash Brown Taha
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
The Clinical Diagnosis of Parkinson's Disease—We Are Getting Better
Ronald B. Postuma, Anthony E. Lang
Movement Disorders (2023) Vol. 38, Iss. 4, pp. 515-517
Closed Access | Times Cited: 8
Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson’s patients
Laura de Boni, Amber Wallis, Aurelia Hays Watson, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 7, pp. 1657-1674
Open Access | Times Cited: 2
A minimally invasive biomarker for sensitive and accurate diagnosis of Parkinson’s disease
Zerui Wang, Tricia Gilliland, Hyun Jo Kim, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 2
α-Synuclein pathology as a target in neurodegenerative diseases
Hye-Jin Park, Tae‐In Kam, Valina L. Dawson, et al.
Nature Reviews Neurology (2024)
Closed Access | Times Cited: 2
New Insights into Potential Biomarkers in Patients with Mild Cognitive Impairment Occurring in the Prodromal Stage of Dementia with Lewy Bodies
Niels Hansen, Caroline Bouter, Sebastian Johannes Müller, et al.
Brain Sciences (2023) Vol. 13, Iss. 2, pp. 242-242
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top